Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report) crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.28 and traded as low as $0.28. Northwest Biotherapeutics shares last traded at $0.28, with a volume of 2,596,458 shares.
Northwest Biotherapeutics Stock Performance
The stock has a market cap of $377.00 million, a P/E ratio of -3.56 and a beta of -0.50. The firm has a 50 day moving average of $0.28 and a two-hundred day moving average of $0.32.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
See Also
- Five stocks we like better than Northwest Biotherapeutics
- Stock Market Upgrades: What Are They?
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- How to Choose Top Rated Stocks
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Do ETFs Pay Dividends? What You Need to Know
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
